Transcatheter Aortic Valve Implantation clinical trials

Explore recruiting transcatheter aortic valve implantation clinical trials.

Recruiting transcatheter aortic valve implantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Transcatheter Aortic Valve Implantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AntiCoagulation versus AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Iron Infusion in Elderly Patients undergoing Transcatheter Aortic Valve Implantation (IRON TAVI) Trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Routine versus selective protamine administration to reduce bleeding complications after transcatheter aortic valve implantation

Netherlands, Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Single antiplatelet treatment with Ticagrelor or Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical trial

Spain, Italy, Portugal

Therapeutic use (Phase IV) EU CTIS Study details

Effect of antifibrotic therapy on regression of myocardial fibrosis after transcatheter aortic valve implantation (TAVI) in aortic stenosis patients with high fibrotic burden

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

ATLANTIS Protamine - Antagonization of heparin with protamine sulfate to reduce all neurologic ischemic and hemorrhagic events after transcatheter aortic valve implantation for aortic stenosis: the ATLANTIS Protamine study.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Transcatheter Aortic Valve Implantation trials by city

Transcatheter Aortic Valve Implantation in Toronto Transcatheter Aortic Valve Implantation in Vancouver Transcatheter Aortic Valve Implantation in Montreal Transcatheter Aortic Valve Implantation in Calgary Transcatheter Aortic Valve Implantation in Edmonton Transcatheter Aortic Valve Implantation in Ottawa Transcatheter Aortic Valve Implantation in Winnipeg Transcatheter Aortic Valve Implantation in Quebec City Transcatheter Aortic Valve Implantation in Hamilton Transcatheter Aortic Valve Implantation in Kitchener Transcatheter Aortic Valve Implantation in London Transcatheter Aortic Valve Implantation in Halifax Transcatheter Aortic Valve Implantation in New York Transcatheter Aortic Valve Implantation in Los Angeles Transcatheter Aortic Valve Implantation in Chicago Transcatheter Aortic Valve Implantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease